Health Canada
Symbol of the Government of Canada
Consumer Product Safety

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2010-0869

2. Registrant Information.

Registrant Reference Number: Prosar 1-20956230

Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation

Address: 400 Plaza Drive

City: Secaucus

Prov / State: New Jersey

Country: USA

Postal Code: 07094-3688

3. Select the appropriate subform(s) for the incident.

Domestic Animal

4. Date registrant was first informed of the incident.

08-DEC-09

5. Location of incident.

Country: UNITED STATES

Prov / State: FLORIDA

6. Date incident was first observed.

07-DEC-09

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

Active(s)

PMRA Registration No.       PMRA Submission No.       EPA Registration No. 2596-78

Product Name: UltraGuard Flea/Tick Powder for Cats 4 oz

  • Active Ingredient(s)
    • TETRACHLORVINPHOS
      • Guarantee/concentration 3.3 %

7. b) Type of formulation.

Dust

Application Information

8. Product was applied?

Yes

9. Application Rate.

Unknown

10. Site pesticide was applied to (select all that apply).

Site: Animal / Usage sur un animal domestique

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

The product was applied to 2 cats on 12/07/2009.

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

Unknown

Subform III: Domestic Animal Incident Report

1. Source of Report

Medical Professional

2. Type of animal affected

Cat / Chat

3. Breed

Domestic Shorthair

4. Number of animals affected

1

5. Sex

Female

6. Age (provide a range if necessary )

1.25

7. Weight (provide a range if necessary )

3.8

lbs

8. Route(s) of exposure

Skin

9. What was the length of exposure?

Unknown / Inconnu

10. Time between exposure and onset of symptoms

Unknown / Inconnu

11. List all symptoms

System

  • Nervous and Muscular Systems
    • Symptom - Muscle weakness
  • Eye
    • Symptom - Nystagmus
  • General
    • Symptom - Death
  • Eye
    • Symptom - Pupil dilation
    • Specify - Myadrisis

12. How long did the symptoms last?

Persisted until death

13. Was medical treatment provided? Provide details in question 17.

Yes

14. a) Was the animal hospitalized?

Yes

14. b) How long was the animal hospitalized?

Unknown

15. Outcome of the incident

Died

16. How was the animal exposed?

Treatment / Traitement

17. Provide any additional details about the incident

(eg. description of the frequency and severity of the symptoms

1-20956230: A reporter (veterinarian) called on 12/08/2009 to report the exposure of 2 cats to a flea and tick powder containing the active ingredient Tetrachlorvinphos. According to the reporter, the product was applied to the cats on 12/07/2009. An unknown time following product application, Cat #1 (1st Subform III) developed weakness, mydriasis, and nystagmus. Cat #2 (2nd Subform III) developed hypersalivation. The cats had presented to the reporter the morning of the report. The reporter was advised that the active ingredient is an organophosphate (OP) with a low order of toxicity when used appropriately. Aggressive use by an owner may result in toxicity. Signs of OP toxicity, including muscarinic and nicotinic signs, were discussed. The reporter was advised about the use of low dose atropine as a diagnostic test and how to interpret the response. A recommendation was made to bathe the cats thoroughly to decontaminate them. A recommendation was also made to treat muscarinic signs with atropine. Doses were discussed. The reporter was advised that nicotinic signs should be treated symptomatically including methocarbamol for muscle tremors and IV Valium or phenobarbital for seizures. The company's cholinesterase testing program was discussed. The reporter called back later on 12/08/2009 to report that Cat #1 had died. A recommendation was made to submit the samples for cholinesterase testing and to consider necropsy. On follow up on 12/11/2009, the reporter stated that Cat #2 had been bathed, monitored for the day and discharged. The owner had not called so the reporter assumed Cat #2 was doing well at home. The reporter called back on 12/11/2009 after speaking with the owner. Cat #2 was reportedly anorexic and had vomited on 12/10/2009. The cat was brought in for re-evaluation and was found to be euhydrated and of stable weight. The reporter was advised that the signs are not typical of OP toxicity if muscarinic and nicotinic signs had not developed. A recommendation was made to treat symptomatically. The cholinesterase testing program was again discussed. On follow up on 12/14/2009, an employee from the veterinary clinic stated that the cat was discharged on 12/12/2009. The owner had not called with any concerns since that point. No further information was obtained.


To be determined by Registrant

18. Severity classification (if there is more than 1 possible classification

Death

19. Provide supplemental information here

Subform III: Domestic Animal Incident Report

1. Source of Report

Medical Professional

2. Type of animal affected

Cat / Chat

3. Breed

Unknown Breed

4. Number of animals affected

1

5. Sex

Female

6. Age (provide a range if necessary )

Unknown

7. Weight (provide a range if necessary )

6.6

lbs

8. Route(s) of exposure

Skin

9. What was the length of exposure?

Unknown / Inconnu

10. Time between exposure and onset of symptoms

Unknown / Inconnu

11. List all symptoms

System

  • Gastrointestinal System
    • Symptom - Salivating excessively
    • Symptom - Anorexia
    • Symptom - Vomiting

12. How long did the symptoms last?

Unknown / Inconnu

13. Was medical treatment provided? Provide details in question 17.

Yes

14. a) Was the animal hospitalized?

Yes

14. b) How long was the animal hospitalized?

Unknown

15. Outcome of the incident

Unknown/Inconnu

16. How was the animal exposed?

Treatment / Traitement

17. Provide any additional details about the incident

(eg. description of the frequency and severity of the symptoms

1-20956230: A reporter (veterinarian) called on 12/08/2009 to report the exposure of 2 cats to a flea and tick powder containing the active ingredient Tetrachlorvinphos. According to the reporter, the product was applied to the cats on 12/07/2009. An unknown time following product application, Cat #1 (1st Subform III) developed weakness, mydriasis, and nystagmus. Cat #2 (2nd Subform III) developed hypersalivation. The cats had presented to the reporter the morning of the report. The reporter was advised that the active ingredient is an organophosphate (OP) with a low order of toxicity when used appropriately. Aggressive use by an owner may result in toxicity. Signs of OP toxicity, including muscarinic and nicotinic signs, were discussed. The reporter was advised about the use of low dose atropine as a diagnostic test and how to interpret the response. A recommendation was made to bathe the cats thoroughly to decontaminate them. A recommendation was also made to treat muscarinic signs with atropine. Doses were discussed. The reporter was advised that nicotinic signs should be treated symptomatically including methocarbamol for muscle tremors and IV Valium or phenobarbital for seizures. The company's cholinesterase testing program was discussed. The reporter called back later on 12/08/2009 to report that Cat #1 had died. A recommendation was made to submit the samples for cholinesterase testing and to consider necropsy. On follow up on 12/11/2009, the reporter stated that Cat #2 had been bathed, monitored for the day and discharged. The owner had not called so the reporter assumed Cat #2 was doing well at home. The reporter called back on 12/11/2009 after speaking with the owner. Cat #2 was reportedly anorexic and had vomited on 12/10/2009. The cat was brought in for re-evaluation and was found to be euhydrated and of stable weight. The reporter was advised that the signs are not typical of OP toxicity if muscarinic and nicotinic signs had not developed. A recommendation was made to treat symptomatically. The cholinesterase testing program was again discussed. On follow up on 12/14/2009, an employee from the veterinary clinic stated that the cat was discharged on 12/12/2009. The owner had not called with any concerns since that point. No further information was obtained.


To be determined by Registrant

18. Severity classification (if there is more than 1 possible classification

Moderate

19. Provide supplemental information here